Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "genentech"

movecoach Moves Genentech

Join the Genentech Movement Challenge powered by movecoach. Sync your favorite device or track with this app, and earn rewards for your activity. See yourself on the leaderboard and show off your activity to co-workers. Access real coaches for ... ZDNet, 3 weeks ago

90 images for genentech

Scrip Intelligence, 2 days ago
Mobihealthnews, 2 weeks ago
U.S. Green Building Council, 4 weeks ago
Asia Today, 1 month ago
San Francisco Chronicle, 1 month ago
PharmaVOICE, 1 month ago
Nasdaq, 1 month ago
BC Technology, 1 month ago
pharmaphorum, 1 month ago
San Francisco Chronicle, 1 month ago
Mobihealthnews

Anthem, Caterpillar, Genentech among Castlight Health's Q2 customer wins

San Francisco-based Castlight Health, which offers a personalized health shopping platform aimed at equipping employees with transparency on both pricing and quality, added some big names to its subscription service and saw increase in both revenue ...
 Mobihealthnews2 weeks ago Syndax Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update  Benzinga.com2 weeks ago MIRNA THERAPEUTICS : Reports Second Quarter 2016 Financial Results and Program Updates  4 Traders1 week ago Mirna Therapeutics Reports Second Quarter 2016 Financial Results and Program Updates August 15, 2016 07:00 AM Eastern Daylight Time  PharmaVOICE1 week ago
[x]  
BioPharma-Reporter.com

Pfenex Eyes "Options" for Lucentis Biosi...

Pfenex said today it will regain full rights to PF582, a biosimilar version of Genentech's eye treatment Lucentis ® (ranibizumab injection) it had been developing with Hospira, after the Pfizer subsidiary ended a collaboration inked last year that ...
 Genetic Engineering News2 weeks ago Formycon up after Pfizer halts Lucentis biosimilar development  BioPharma-Reporter.com2 weeks ago One in the eye for Pfenex? Pfizer abandons Lucentis biosimilar programme  BioPharma-Reporter.com2 weeks ago

ORIC Hires Genentech's Hanna as CEO, Adds New Chief Business Officer

South San Francisco, CA-based ORIC Pharmaceuticals has named Ashraf Hanna its CEO, replacing Rich Heyman, who helped ORIC raise a $53 million Series B in December while filling the role on an interim basis. Hanna was previously a commercial and ...
 Xconomy2 weeks ago Calithera Biosciences Appoints Suzy Jones to Board of Directors  Stockwatch2 weeks ago ORIC Pharmaceuticals Appoints Ashraf Hanna, PhD, MD, as Chief Executive Officer, and Darcy Mootz, PhD, as Chief Business Officer  Benzinga.com2 weeks ago CALITHERA BIOSCIENCES : Appoints Suzy Jones to Board of Directors  4 Traders2 weeks ago
[x]  

Investigators from Genentech, Inc. Have Reported New Data on Small Cell Lung Cancer (Modeling and simulation of maintenance treatment in first-line...

 4 Traders2 weeks ago

Reports Outline Nephrology Findings from Genentech, Inc. (Targeting Cell Death Pathways for Therapeutic Intervention in Kidney Diseases)

By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Health and Medicine have been published. According to news reporting from San Francisco, California, by NewsRx journalists, research stated, "Precise ...
 4 Traders2 weeks ago AbbVie Announces Initiation of Phase 3 Study of Venetoclax in Patients with Relapsed or Refractory Multiple Myeloma  4 Traders3 weeks ago

Cancer Vaccines: Abzena and Genentech go Under the Microscope in Exclusive New Interviews

Aug. 10, 2016, 12:04 p.m. SMi Group add two new Q&A's to the cancer vaccines interview series with Abzena and Genentech in the run up to their keynote addresses at Cancer Vaccines 2016 SMi's 5th annual Cancer Vaccines conference will return to ...
 BioPharma Dive2 weeks ago CANCER VACCINES : Abzena and Genentech go Under the Microscope in Exclusive New Interviews  4 Traders2 weeks ago

Genentech's PD-L1 agent approved for bladder cancer

Download the PDF here The US Food and Drug Administration (FDA)'s approval in May of Genentech's Tecentriq (atezolizumab) is the first for a cancer immunotherapy targeting programmed cell death-ligand 1 (PD-L1). It also marks the first new drug ...
 National AIDS Treatment Advocacy Project2 weeks ago FDA Approves Generic Tamiflu  Pharmscope3 weeks ago

Studies from Genentech, Inc. Have Provided New Information about Colon Cancer (The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged…

Studies from Genentech, Inc. Have Provided New Information about Colon Cancer (The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64 Years) By a News Reporter-Staff News Editor at Insurance Weekly News -- Investigators ...
 Insurance News Net3 weeks ago

ROCHE : Genentech brings STEM to kids

Aug. 03--The Boys & Girls Clubs of Oceanside hosted Genentech volunteers for the third summer to run a Science, Technology, Engineering and Math (STEM) program for more than 300 campers. Teens were selected to tour the Genentech Oceanside facility ...
 4 Traders3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - genentech
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less